Gradhand Ulrike, Tegude Heike, Burk Oliver, Eichelbaum Michel, Fromm Martin F, König Jörg
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuremberg, Fahrstr. 17, 91054 Erlangen, Germany.
Life Sci. 2007 Mar 27;80(16):1490-4. doi: 10.1016/j.lfs.2007.01.023. Epub 2007 Jan 20.
The multidrug resistance protein 3 (MRP3/gene symbol: ABCC3) is an ATP-dependent efflux pump mediating the transport of endogenous glucuronides and conjugated drug metabolites across cell membranes. In humans the hepatic expression of ABCC3 mRNA seems to be influenced by the polymorphism C>T at the position -211 in the promoter of the ABCC3 gene. The aim of this study was to investigate the possible mechanisms of how this SNP influences the MRP3 expression. Promoter luciferase reporter gene constructs representing 0.5, 1.1, 4.4, and 8.1 kb upstream of the translational start site were cloned with cytosine or thymine at position -211 and transfected into HepG2, Caco-2, and LS174T cells. Reporter gene activity was dependent on the length of the promoter sequence but interestingly not on the nucleotide at position -211. Cotransfection with FTF cDNA (Fetoprotein Transcription Factor) binding to elements near the -211 polymorphism increased promoter activity in all constructs except the 0.5 kb fragment also independently of the -211 SNP. Taken together, we did not find any influence of the -211C>T ABCC3 promoter polymorphism on either the basal or the FTF induced reporter gene activity. Whether other tissue specific mechanisms reveal an impact of this SNP on the in vivo regulation of MRP3 remains to be determined.
多药耐药蛋白3(MRP3/基因符号:ABCC3)是一种ATP依赖性外排泵,介导内源性葡糖醛酸苷和结合型药物代谢物跨细胞膜的转运。在人类中,ABCC3 mRNA的肝脏表达似乎受ABCC3基因启动子中-211位C>T多态性的影响。本研究的目的是探讨该单核苷酸多态性(SNP)影响MRP3表达的可能机制。克隆了翻译起始位点上游0.5、1.1、4.4和8.1 kb的启动子荧光素酶报告基因构建体,其-211位为胞嘧啶或胸腺嘧啶,并转染至HepG2、Caco-2和LS174T细胞中。报告基因活性取决于启动子序列的长度,但有趣的是,不取决于-211位的核苷酸。与结合在-211多态性附近元件的FTF cDNA(甲胎蛋白转录因子)共转染,除0.5 kb片段外,所有构建体中的启动子活性均增加,且也独立于-211 SNP。综上所述,我们未发现ABCC3启动子-211C>T多态性对基础或FTF诱导的报告基因活性有任何影响。该SNP对MRP3体内调节的影响是否通过其他组织特异性机制揭示仍有待确定。